Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers 2024-04-26 21:00
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa 2024-04-26 12:39
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor 2024-04-25 22:00
PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono 2024-04-25 14:00
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST 2024-04-25 09:02
Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting 2024-04-24 22:10
Future Health highlights greater access to treatment for Mental Health Month 2024-04-24 22:00
Samsung Biologics Reports First Quarter 2024 Financial Results 2024-04-24 14:45
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab) 2024-04-24 09:27
OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market 2024-04-23 18:37
HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML) 2024-04-23 14:54
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre-A+ Financing 2024-04-23 08:00
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024 2024-04-23 07:25
Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial 2024-04-22 20:30
GT20029 China Phase II Trial For AGA Reached Primary Endpoint 2024-04-22 09:53
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards 2024-04-22 09:00
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer 2024-04-19 19:00
TaiGen Successfully Completes TG-1000 Phase III Study 2024-04-18 11:03
Henlius Releases 2023 ESG Report: Pursuing Sustainable Development with Patient-centricity 2024-04-17 20:32
Kind Pharmaceuticals Announces Settlement 2024-04-17 00:17
1 2 3 4 5 146